Cannabis Regulations Harmonized with Controlled Substances

Summary#

This is a proposal to change the Cannabis Regulations so some rules match parts of the Controlled Substances Regulations. The changes were published by the Department of Health for public comment for 60 days and, if adopted, would come into force on the 365th day after they appear in the Canada Gazette, Part II.

What it does#

• Updates several definitions (for example, how a “test kit”, “combination product”, and the terms linked to prescription drugs are described) to align with drug rules.
• Creates and recognizes a new category called a licensed dealer specialized in destruction and sets who can witness and attest to the destruction of cannabis products.
• Lets individuals hand over cannabis to a pharmacist (not working in a hospital) for destruction, and treats that cannabis as a controlled substance for the purpose of destruction.
• Changes what information must appear on orders and records for prescription cannabis products, including requiring brand names and drug identification numbers (DINs) in many cases.
• Expands and clarifies what pharmacists, hospitals and practitioners can do with prescription cannabis drugs (selling, distributing, administering) and the written-order and record-keeping rules that must accompany those activities.
• Adds record-keeping and business rules for licensed dealers who receive, sell or transfer drugs containing cannabis for destruction; records must be kept for two years in certain cases.
• Sets rules for travellers: an individual may import or export a drug containing cannabis if it is declared at the border, properly labelled with specific information, and does not exceed a 90-day supply.
• Creates a registration and oversight scheme for cannabis test kits, including grounds for refusing a registration if the kit could pose a public‑health or diversion risk.
• Updates who must have specific knowledge or credentials (for example, master growers, responsible persons, analytical testing staff) and how foreign credentials can be validated.
• Replaces certain wording (for example, “statement” becomes “attestation”) and makes a number of bilingual (French) wording adjustments to reflect the updated terms.

Who's affected#

• Pharmacists and hospital pharmacies — new rules on what they can receive, sell, distribute, destroy and record for prescription cannabis drugs.
• Licensed dealers and the newly defined licensed dealer specialized in destruction — new roles, witness and record rules for destruction and transfers for destruction.
• Practitioners and hospitals that handle drugs containing cannabis — changes to ordering, record-keeping and possession rules.
• Manufacturers and assemblers of cannabis test kits — new registration requirements and possible refusal grounds.
• People who possess prescription cannabis products, and travellers carrying them — new import/export labeling and declaration rules (up to a 90-day supply).
• Cultivation and lab staff such as “master growers” and analytical testing personnel — clarified expectations about knowledge and credentials.
• General public and businesses that use or move prescription cannabis products may notice clearer labelling and tighter controls.

If it isn’t clear from this summary whether a specific business or activity is covered, the full proposal lists precise wording and which parts of the rules change.

Why it matters#

• The package aims to reduce confusion by aligning cannabis drug rules with existing controlled-substance rules. That should make it clearer who can do what with prescription cannabis (sell, distribute, destroy) and what records must be kept.
• For patients and travellers, the proposal clarifies when and how prescription cannabis can cross borders and what labels and documentation are needed.
• For pharmacists, dealers and destruction specialists, the changes change operational steps: who can witness destruction, what information must be recorded, and how products are transferred for destruction.
• For test-kit makers and regulators, the registration rules are meant to reduce the risk that kits could make cannabis available for improper use.
• This is a proposal, not final law. The government invited comments for 60 days; the rules would only take effect if finalized, with an effective date set as the 365th day after publication in Canada Gazette, Part II.